Empowering mental health professionals with peer-reviewed psychiatric research and insights
Page 32
More JCP Articles
Original Research
Differences Among Second-Generation Antipsychotics in Effects on HbA1c
March 30, 2022
The antipsychotic blonanserin was associated with less change in glycated hemoglobin (HbA1c) levels than olanzapine, and changes in BMI were lower for both blonanserin and aripiprazole. Study results indicate…
Clinical and Practical Psychopharmacology
Insights on Use of Ketamine From RCTs of Ketamine vs Electroconvulsive Therapy in Severe Depression
March 28, 2022
ECT outperformed ketamine in recent randomized controlled trials. These studies also, however, shed light on ketamine’s potential as a viable alternative to ECT in some severely depressed patients.
Original Research
Quetiapine XR in Comorbid Depression and Anxiety
March 21, 2022
Quetiapine is often used off-label for anxiety and as an augmentation agent in treatment-resistant depression. This study evaluated the efficacy and tolerability of quetiapine in augmenting first-line antidepressants for…
Original Research
Deimplementation of Benzodiazepine Prescribing for PTSD Among Veterans
March 14, 2022
Given concerns about inappropriate prescribing in post-9/11 veterans, a goal of the Veterans Health Administration has been to reduce off-label prescribing practices. This study tracks benzodiazepine prescribing for PTSD…
Original Research
HSA-HDHPs and Bipolar Disorder Medication Cost Burden
March 9, 2022
This study examined the effects of high-deductible health plans paired with health savings accounts (HSA-HDHPs)—which require substantial out-of-pocket spending for most services—on medication out-of-pocket spending in people with bipolar…
